The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain - PubMed (original) (raw)
. 2000 Sep 5;39(35):10831-9.
doi: 10.1021/bi001048s.
Affiliations
- PMID: 10978169
- DOI: 10.1021/bi001048s
The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain
D M Walsh et al. Biochemistry. 2000.
Abstract
The progressive aggregation and deposition of amyloid beta-protein (Abeta) in brain regions subserving memory and cognition is an early and invariant feature of Alzheimer's disease, the most common cause of cognitive failure in aged humans. Inhibiting Abeta aggregation is therapeutically attractive because this process is believed to be an exclusively pathological event. Whereas many studies have examined the aggregation of synthetic Abeta peptides under nonphysiological conditions and concentrations, we have detected and characterized the oligomerization of naturally secreted Abeta at nanomolar levels in cultures of APP-expressing CHO cells [Podlisny, M. B., Ostaszewski, B. L., Squazzo, S. L., Koo, E. H., Rydell, R. E., Teplow, D. B., and Selkoe, D. J. (1995) J. Biol. Chem. 270, 9564-9570 (1); Podlisny, M. B., Walsh, D. M., Amarante, P., Ostaszewski, B. L., Stimson, E. R., Maggio, J. E., Teplow, D. B., and Selkoe, D. J. (1998) Biochemistry 37, 3602-3611 (2)]. To determine whether similar species occur in vivo, we probed samples of human cerebrospinal fluid (CSF) and detected SDS-stable dimers of Abeta in some subjects. Incubation of CSF or of CHO conditioned medium at 37 degrees C did not lead to new oligomer formation. This inability to induce oligomers extracellularly as well as the detection of oligomers in cell medium very early during the course of pulse-chase experiments suggested that natural Abeta oligomers might first form intracellularly. We therefore searched for and detected intracellular Abeta oligomers, principally dimers, in primary human neurons and in neuronal and nonneural cell lines. These dimers arose intracellularly rather than being derived from the medium by reuptake. The dimers were particularly detectable in neural cells: the ratio of intracellular to extracellular oligomers was much higher in brain-derived than nonbrain cells. We conclude that the pathogenically critical process of Abeta oligomerization begins intraneuronally.
Similar articles
- Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red.
Podlisny MB, Walsh DM, Amarante P, Ostaszewski BL, Stimson ER, Maggio JE, Teplow DB, Selkoe DJ. Podlisny MB, et al. Biochemistry. 1998 Mar 17;37(11):3602-11. doi: 10.1021/bi972029u. Biochemistry. 1998. PMID: 9521679 - Valproic acid and its congener propylisopropylacetic acid reduced the amount of soluble amyloid-β oligomers released from 7PA2 cells.
Williams RSB, Bate C. Williams RSB, et al. Neuropharmacology. 2018 Jan;128:54-62. doi: 10.1016/j.neuropharm.2017.09.031. Epub 2017 Sep 22. Neuropharmacology. 2018. PMID: 28947378 - Intracellular metalloprotease activity controls intraneuronal Aβ aggregation and limits secretion of Aβ via exosomes.
Pacheco-Quinto J, Clausen D, Pérez-González R, Peng H, Meszaros A, Eckman CB, Levy E, Eckman EA. Pacheco-Quinto J, et al. FASEB J. 2019 Mar;33(3):3758-3771. doi: 10.1096/fj.201801319R. Epub 2018 Nov 27. FASEB J. 2019. PMID: 30481490 Free PMC article. - Alzheimer's disease.
De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV. De-Paula VJ, et al. Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review. - The redox chemistry of the Alzheimer's disease amyloid beta peptide.
Smith DG, Cappai R, Barnham KJ. Smith DG, et al. Biochim Biophys Acta. 2007 Aug;1768(8):1976-90. doi: 10.1016/j.bbamem.2007.02.002. Epub 2007 Feb 9. Biochim Biophys Acta. 2007. PMID: 17433250 Review.
Cited by
- β-amyloid monomer scavenging by an anticalin protein prevents neuronal hyperactivity in mouse models of Alzheimer's Disease.
Zott B, Nästle L, Grienberger C, Unger F, Knauer MM, Wolf C, Keskin-Dargin A, Feuerbach A, Busche MA, Skerra A, Konnerth A. Zott B, et al. Nat Commun. 2024 Jul 10;15(1):5819. doi: 10.1038/s41467-024-50153-y. Nat Commun. 2024. PMID: 38987287 Free PMC article. - Nano-infrared analysis of amyloid β1-42 fibrils formed in the presence of lipids with unsaturated fatty acids.
Zhaliazka K, Kurouski D. Zhaliazka K, et al. Nanoscale. 2023 Dec 14;15(48):19650-19657. doi: 10.1039/d3nr05184f. Nanoscale. 2023. PMID: 38019134 - The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design.
Tundo GR, Grasso G, Persico M, Tkachuk O, Bellia F, Bocedi A, Marini S, Parravano M, Graziani G, Fattorusso C, Sbardella D. Tundo GR, et al. Biomolecules. 2023 Oct 7;13(10):1492. doi: 10.3390/biom13101492. Biomolecules. 2023. PMID: 37892174 Free PMC article. Review. - The Effect of Ultrasonication on the Fibrillar/ Oligomeric Structures of Aβ1-42 at Different Concentrations.
Faridi N, Sanjari-Pour M, Wang P, Bathaie SZ. Faridi N, et al. Protein J. 2023 Oct;42(5):575-585. doi: 10.1007/s10930-023-10138-0. Epub 2023 Aug 27. Protein J. 2023. PMID: 37634212 Free PMC article. - Transcranial Electromagnetic Wave Treatment: A Fountain of Healthy Longevity?
Arendash G, Cao C. Arendash G, et al. Int J Mol Sci. 2023 Jun 2;24(11):9652. doi: 10.3390/ijms24119652. Int J Mol Sci. 2023. PMID: 37298603 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources